We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£795.00
The 2023-2028 World Outlook for Guillain-Barre Syndrome Therapeutics
Price data last checked 120 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£795 today · cheaper than every other day in the last 6 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 74 days • 74 data points (No recent data available)
Price Distribution
Price distribution over 74 days • 1 price levels
Price Analysis
Most common price: £795 (74 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 74 days
Product Specifications
- Format
- Paperback
- ASIN
- B09YHRM7J7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 10 May 2022
- Listed Since
- 06 May 2022
Similar Products You Might Like
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in China
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in Japan
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics for US Zip Codes
The 2023-2028 Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes for US Zip Codes
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States
The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in the United States
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
The 2023-2028 World Outlook for Gallium Nitride (GaN)-on-Silicon (Si) Renewables and Grids
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in India
The 2025-2030 World Outlook for Amyotrophic Lateral Sclerosis
The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in Greater China
The 2013-2018 Outlook for Lou Gehrig's Disease Drugs in India
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
The 2023-2028 Outlook for Gamified Healthcare Solutions in the United States
The 2023-2028 Outlook for Myasthenia Gravis in India
The 2023-2028 World Outlook for Web-Based Serious Games
The 2023-2028 Outlook for Gram-Positive Bacterial Infections in the United States
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India
The 2026-2031 World Outlook for Glycolic Acids
The 2023-2028 Outlook for Digital Games Software in the United States
